[1]Rodat,Theo;Krebs,Melanie;Döbber,Alexander;Jansen,Björn;Steffen-Heins,Anja;Schwarz,Karin;Peifer,Christian[PhotochemicalandPhotobiologicalSciences,2020,vol.19,#10,p.1319-1325]
[1]Rodat,Theo;Krebs,Melanie;Döbber,Alexander;Jansen,Björn;Steffen-Heins,Anja;Schwarz,Karin;Peifer,Christian[PhotochemicalandPhotobiologicalSciences,2020,vol.19,#10,p.1319-1325]
Title: AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts.
Journal: Molecular cancer therapeutics 20090701
Title: Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20081215
Title: The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing.
Journal: Bioorganic & medicinal chemistry letters 20081215
Title: Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20081015
Title: Cyclin-dependent kinase pathways as targets for cancer treatment.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060410
Title: Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Journal: Frontiers in bioscience : a journal and virtual library 20060101
Title: Mammalian cyclin-dependent kinases.
Journal: Trends in biochemical sciences 20051101
Title: Cyclin D-dependent kinases, INK4 inhibitors and cancer.
Journal: Biochimica et biophysica acta 20020314
Title: Byth KF, et al. AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. Mol Cancer Ther. 2009 Jul;8(7):1856-66. Epub 2009 Jun 9.
Title: Raghavan P, et al. AZD5438, an Inhibitor of Cdk1, 2, and 9, Enhances the Radiosensitivity of Non-Small Cell Lung Carcinoma Cells. Int J Radiat Oncol Biol Phys. 2012 Jul 12.
